Compliance with transparency guideline for the relation between corporate activities and medical institutes

Takara Bio engages in clinical and commercial development of advanced technology for gene therapy and cell therapy. With such efforts, we recognize a responsibility for social network with researchers, medical personnel, patients and others while ensuring the ethics and transparency. Based on the politics and guideline such as the code of practice, transparency guideline for the relation between corporate activities and medical institutes, transparency guideline for the relation between corporate activities and patient organizations, etc. stated in Japan Pharmaceutical Manufacturers Association, we disclose any information with respect to activities in Gene Therapy business in accordance with our transparency guideline for the relation with medical institutes, etc. and patient organizations as formulated.

The details are available only in Japanese here.